Designing Alginate/Chitosan Nanoparticles Containing Echinacea angustifolia : A Novel Candidate for Combating Multidrug‐Resistant Staphylococcus aureus
Abstract Nanoparticles (NPs) may help treat multidrug‐resistant Staphylococcus aureus(MDR). This study prepared and evaluated chitosan/alginate‐encapsulated Echinacea angustifolia extract against MDR strains. Evaluating synthesized NPs with SEM, DLS, and FT‐IR. Congo red agar and colorimetric plate techniques examined isolate biofilm formation. NP antibacterial power was assessed using well diffusion. Real‐time PCR assessed biofilm‐forming genes. MTT assessed the synthesized NPs′ toxicity. According to DLS measurements, spherical E. angustifolia NPs had a diameter of 335.3±1.43 nm. The PDI was 0.681, and the entrapment effectiveness (EE%) of the E. angustifolia extract reached 83.45 %. Synthesized NPs were most antimicrobial. S. aureus resistant to several treatments was 80 percent of 100 clinical samples. Biofilm production was linked to MDR in all strains. The ALG/CS‐encapsulated extract had a 4 to 32‐fold lower MIC than the free extract, which had no bactericidal action. They also significantly decreased the expression of genes involved in biofilm formation. E. angustifolia‐encapsulated ALG/CS decreased IcaD, IcaA, and IcaC gene expression in all MDR strains (***p<0.001). Free extract, free NPs, and E. angustifolia‐NPs had 57.5 %, 85.5 %, and 90.0 % cell viability at 256 μg/ml. These discoveries could assist generate stable plant extracts by releasing natural‐derived substances under controlled conditions..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Chemistry & Biodiversity - 20(2023), 7 |
| Beteiligte Personen: |
Taghiloo, Sepideh [VerfasserIn] |
|---|
| Anmerkungen: |
© 2023 Wiley‐VHCA AG, Zurich, Switzerland |
|---|
| Umfang: |
13 |
|---|
| doi: |
10.1002/cbdv.202201008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY015251942 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY015251942 | ||
| 003 | DE-627 | ||
| 005 | 20231111134448.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231111s2023 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1002/cbdv.202201008 |2 doi | |
| 028 | 5 | 2 | |a 2023-11-11_CBDV_2023_20_7.zip.xml |
| 035 | |a (DE-627)WLY015251942 | ||
| 035 | |a (WILEY)CBDV202201008 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 100 | 1 | |a Taghiloo, Sepideh |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Designing Alginate/Chitosan Nanoparticles Containing Echinacea angustifolia |b A Novel Candidate for Combating Multidrug‐Resistant Staphylococcus aureus |
| 264 | 1 | |c 2023 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © 2023 Wiley‐VHCA AG, Zurich, Switzerland | ||
| 520 | |a Abstract Nanoparticles (NPs) may help treat multidrug‐resistant Staphylococcus aureus(MDR). This study prepared and evaluated chitosan/alginate‐encapsulated Echinacea angustifolia extract against MDR strains. Evaluating synthesized NPs with SEM, DLS, and FT‐IR. Congo red agar and colorimetric plate techniques examined isolate biofilm formation. NP antibacterial power was assessed using well diffusion. Real‐time PCR assessed biofilm‐forming genes. MTT assessed the synthesized NPs′ toxicity. According to DLS measurements, spherical E. angustifolia NPs had a diameter of 335.3±1.43 nm. The PDI was 0.681, and the entrapment effectiveness (EE%) of the E. angustifolia extract reached 83.45 %. Synthesized NPs were most antimicrobial. S. aureus resistant to several treatments was 80 percent of 100 clinical samples. Biofilm production was linked to MDR in all strains. The ALG/CS‐encapsulated extract had a 4 to 32‐fold lower MIC than the free extract, which had no bactericidal action. They also significantly decreased the expression of genes involved in biofilm formation. E. angustifolia‐encapsulated ALG/CS decreased IcaD, IcaA, and IcaC gene expression in all MDR strains (***p<0.001). Free extract, free NPs, and E. angustifolia‐NPs had 57.5 %, 85.5 %, and 90.0 % cell viability at 256 μg/ml. These discoveries could assist generate stable plant extracts by releasing natural‐derived substances under controlled conditions. | ||
| 700 | 1 | |a Ghajari, Ghazal |4 aut | |
| 700 | 1 | |a Zand, Zahra |4 aut | |
| 700 | 1 | |a Kabiri‐Samani, Saber |4 aut | |
| 700 | 1 | |a Kabiri, Hamidreza |4 aut | |
| 700 | 1 | |a Rajaei, Negin |4 aut | |
| 700 | 1 | |a Piri‐Gharaghie, Tohid |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chemistry & Biodiversity |g 20(2023), 7 |w (DE-627)WLY003111520 |x 16121880 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2023 |g number:7 |g extent:13 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2023 |e 7 |g 13 | ||